申请人:BASF Aktiengesellschaft
公开号:US04463007A1
公开(公告)日:1984-07-31
1,2,4-Triazolo[1,5-c]-quinazolinones of the general formula I ##STR1## and their pharmaceutically tolerated salts, processes for their preparation and pharmaceutical formulations which contain these compounds and are useful drugs in the treatment of allergic disorders.
本发明涉及一般式I的1,2,4-三唑并[1,5-c]-喹唑啉酮及其药学上可耐受的盐,制备它们的方法以及包含这些化合物的制药配方,这些化合物是治疗过敏性疾病的有用药物。